Remestemcel-L allogeneic bone marrow-derived mesenchymal stem cell product to treat medically refractory Crohn's colitis: preliminary phase IB/IIA study.

Lightner, Amy L; Ream, Justin; Nachand, Douglas; Fulmer, Clifton; Regueiro, Miguel; Steele, Scott R

Lightner, Amy L; Ream, Justin; Nachand, Douglas; Fulmer, Clifton; Regueiro, Miguel; Steele, Scott R.

Afiliação

Lightner AL; Department of Colorectal Surgery, Digestive Disease and Surgery Institute, Cleveland Clinic, Ohio, USA.
Ream J; Department of Radiology, Imaging Institute, Cleveland Clinic, Ohio, USA.
Nachand D; Department of Radiology, Imaging Institute, Cleveland Clinic, Ohio, USA.
Fulmer C; Department of Pathology, Digestive Disease and Surgery Institute, Cleveland Clinic, Ohio, USA.
Regueiro M; Department of Colorectal Surgery, Digestive Disease and Surgery Institute, Cleveland Clinic, Ohio, USA.
Steele SR; Department of Colorectal Surgery, Digestive Disease and Surgery Institute, Cleveland Clinic, Ohio, USA.

Br J Surg ; 109(8): 653-655, 2022 07 15.

Article em En | MEDLINE | ID: mdl-35714218

Assuntos

Colite; Doença de Crohn; Transplante de Células-Tronco Hematopoéticas; Transplante de Células-Tronco Mesenquimais; Células-Tronco Mesenquimais; Produtos Biológicos; Medula Óssea; Doença de Crohn/terapia; Humanos

Texto completo

Imprimir

XML

PubMed Links

Buscar no Google

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Assunto principal: Doença de Crohn / Colite / Transplante de Células-Tronco Hematopoéticas / Transplante de Células-Tronco Mesenquimais / Células-Tronco Mesenquimais Limite: Humans Idioma: En Ano de publicação: 2022 Tipo de documento: Article

Texto completo

Imprimir

XML

PubMed Links

Buscar no Google